Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons

Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02589769
Collaborator
(none)
83
1
2
17
4.9

Study Details

Study Description

Brief Summary

A randomized controlled clinical trial comparing the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

Condition or Disease Intervention/Treatment Phase
  • Other: unsaturated fat for saturated fat
  • Other: saturated fat
N/A

Detailed Description

Background: Increased intake of saturated fat may influence LDL cholesterol and other cardiovascular risk factors different in normal weight and obese subjects. Methods: The study is a randomized controlled clinical trial in 84 men and women between 21 to 70 years with normal BMI (25 kg/m2) or obesity (BMI 30-45 kg/m2) and elevated LDL cholesterol (>3.0 mmol/l). Dietary intervention: Randomization will be to one of two balanced weight maintenance Mediterranean-type diets that differ in their fat sources: an intervention diet substituting unsaturated fats from oil and nuts for saturated fats from meat and dairy foods, and a control diet with whole fat dairy and meat with saturated fats that are not fat reduced.

Primary research question: Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

Secondary research questions: Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on cardiometabolic risk factors including insulin resistance, inflammation and serum PCSK9 in normal weight and obese individuals.

Study Design

Study Type:
Interventional
Actual Enrollment :
83 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Feb 1, 2018
Actual Study Completion Date :
Feb 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: unsaturated fat

an intervention diet substituting unsaturated fats from oil and nuts for saturated fats from meat and dairy foods

Other: unsaturated fat for saturated fat
Substituting unsaturated fat for saturated fat

Active Comparator: saturated fat

a control diet with whole fat dairy and meat with saturated fats that are not fat reduced.

Other: saturated fat
a control diet with whole fat dairy and meat with saturated fats that are not fat reduced

Outcome Measures

Primary Outcome Measures

  1. Serum lipids in normal weight and obese subjects with elevated LDL cholesterol. [10 weeks]

    Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

Secondary Outcome Measures

  1. C-reactive protein in normal weight and obese individuals [10 weeks]

    Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on c-reactive protein in normal weight and obese individuals

  2. Serum PCSK9 in normal weight and obese individuals [10 weeks]

    Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on inflammation in normal weight and obese individuals

  3. Fasting glucose and HbA1C [10 weeks]

    Compare the effect of substitution of unsaturated fat from nuts and oils for saturated fat on fasting glucose and HbA1C

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women aged 21 to 70 years with normal BMI (25 kg/m2) or obesity (BMI 30-45 kg/m2) and elevated LDL cholesterol (> 3.0 mmol/l).
Exclusion Criteria:
  • Diabetes types 1 and 2

  • History of CVD including myocardial infarction, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), stroke, transient ischemic attack (TIA) or other atherosclerotic disease, eating disorder and other secondary causes of hyperlipidemia.

  • Use of statins or other cholesterol-modifying drugs.

  • Genetic lipid disorder.

  • Gastrointestinal disorders that limit food choices.

  • Psychiatric illness, drug or alcohol abuse.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oslo Universitetssykehus, Ullevål Oslo Norway 0424

Sponsors and Collaborators

  • Oslo University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tine Mejlbo Sundfør, M.Sc in Nutrition, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT02589769
Other Study ID Numbers:
  • 1786 (REK(
First Posted:
Oct 28, 2015
Last Update Posted:
Apr 5, 2018
Last Verified:
Sep 1, 2016
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2018